Colin Lunt
About Colin Lunt
Colin Lunt is a Director Clinical Scientist with extensive experience in clinical trials and project management across various pharmaceutical companies. He currently works at Adaptimmune and has a strong focus on expanding clinical trials into new European countries.
Work at Adaptimmune
Colin Lunt serves as the Director Clinical Scientist at Adaptimmune, a role he has held since 2019. In this position, he focuses on expanding clinical trials into new countries within Europe. He acts as the main contact for coordinating cell collection and manufacturing in clinical studies, ensuring that the processes align with the company’s objectives in T-cell receptor therapy.
Previous Experience in Clinical Trials
Before joining Adaptimmune, Colin Lunt accumulated extensive experience in clinical trials. He worked at The Christie NHS Foundation Trust as a Clinical Trials Project Manager from 2012 to 2015. His earlier roles include Senior Associate Project Manager at Cenduit and Senior Clinical Support Specialist at Phlexglobal, where he developed skills in managing clinical projects and supporting trial operations.
Educational Background
Colin Lunt studied at The University of Salford, where he earned a BSc Joint Honours Degree in Biology and Information Technology from 1999 to 2002. This educational foundation provided him with the necessary knowledge and skills to pursue a career in clinical science and project management within the healthcare sector.
Professional Relationships and Contributions
In his current role and previous positions, Colin Lunt has built relationships with leading investigators and institutions in the T-cell receptor therapy space. He provides scientific input for core documents related to clinical studies and oversees vendors, ensuring compliance with clinical study protocols. His expertise contributes to the advancement of clinical research initiatives.
Career Progression
Colin Lunt has progressed through various roles in the clinical research field. His career includes positions at Amgen, Eisai EMEA, and University College London, where he served as a Senior Data Manager and Trial Coordinator. This diverse experience has equipped him with a comprehensive understanding of clinical trial management and operational strategies.